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fediastinal lymph node assessment is an essential com-
ponent of the surgical management of lung cancer.
raditionally, a potentially curative resection is considered to
nvolve the complete resection of the primary tumor with
icroscopically benign resection margins, and a systematic
issection of lymphatic drainage to accessible mediastinal
odes. Defining the extent of lymph node involvement is
mportant for accurate staging and prognostic guidance. Ac-
urate lymph node assessment also guides the decision to use
djuvant therapy after resection.
In the management of lung cancer, several approaches are
sed to evaluate the extent of mediastinal lymph node in-
olvement. Cervical mediastinoscopy and parasternal medi-
stinotomy are frequently performed to determine if meta-
tatic disease is present in the mediastinal lymph nodes and
hether patients should undergo primary resection. When
erforming mediastinoscopy, we routinely use a video-as-
isted mediastinoscopic technique; this technique has been
emonstrated to have a very high specificity for the absence
f mediastinal metastasis.1 At thoracotomy, systematic medi-
stinal lymph node sampling (SS), which involves the biopsy
f lymph nodes at each of the ipsilateral thoracic mediastinal
ymph node stations, can be performed and is considered the
inimally acceptable approach to intraoperative staging (see
ig 1). Alternatively, complete mediastinal lymph node
issection (MLND), which includes removal of all medi-
stinal nodes within the ipsilateral hemithorax (paratra-
heal and/or subaortic, subcarinal, and nodes near the
nferior pulmonary ligament) provides a more complete
ssessment of lymph node involvement. Extended lymph
ode dissection refers to excision of lymph nodes beyond
he ipsilateral hemithorax, or the use of a separate incision
o complete a nodal excision. As part of a potentially cur-
tive resection for lung cancer, we routinely perform a
omplete MLND.
Our technique of MLND was initially described by Cahan
nd further refined by Martini.2-4 In general, we perform
LND as the first step of the operation, submitting the lymph
odes for frozen section to confirm that the planned pulmo-
ary resection is appropriate. The dissection is generally safe
nd easy to do, adding approximately 20 to 30 minutes of
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doi:10.1053/j.optechstcvs.2005.06.003perative time without added morbidity.5 The presence of me-
iastinal nodal metastases that have bypassed or “skipped” in-
rapulmonary (N1 station) nodes can occur in up to 38% of
atients, which makes the staging of mediastinal nodal stations
mandatory component of the intraoperative evaluation of a
ung cancer.6,7 When compared with SS, MLND identifies
ore levels of mediastinal nodal metastasis (N2 disease).8
efining this multilevel degree of metastasis has prognostic
mportance. As many as one third of patients with mediasti-
al nodal disease may have only 1 node involved.9 In surgi-
ally resected patients who undergo an MLND with medias-
inal nodal metastasis confined to 1 node, 5-year survival
ay be as high as 43%.9-11 This is improved survival com-
ared with multilevel metastasis.9 In those patients with a
imited burden of local-regional nodal metastasis, resection
f mediastinal nodes may improve survival.8,12 Thus, com-
lete MLND at least accurately defines the extent of disease
ndmay improve survival in some patients.13,14 The results of
recent prospective, randomized, multicenter North Amer-
can trial confirm the safety of MLND relative to SS.15 Long-
erm follow-up from this trial will be required to determine
hether MLND confers a survival benefit in patients with
tages I and II non-small cell lung cancer.
With the development of minimally invasive approaches
o the surgical resection of lung cancer, we have continued to
pply our goals of complete MLND. Video-assisted thoracic
urgery (VATS) lobectomy has become a viable treatment
ption for patients with early stage lung cancer, especially
linical stage IA.16,17 Potential advantages include shorter
ength of stay, less postoperative pain, more rapid recovery
ith return to full activity, and lower overall cost. Although
he surgical approach to node dissection is similar, the tech-
ical challenges of VATS involve a learning curve.16-19 To
essen the chance of insufficient mediastinal node resection
n the VATS management of a lung cancer, one may1 do
outine meticulous cervical mediastinoscopy and/or2 limit
horacoscopic dissection to patients with smaller tumors
2.0 cm). The prevalence of mediastinal nodal metastasis
or patients with a tumor less than 2 cm in size ranges from
% to 12%.20,21 Meticulous mediastinoscopy and limiting
ATS lobectomy to patients with tumors 2.0 cm or less in size
s a reasonable approach for surgeons gaining proficiency
ith a thoracoscopic approach to MLND. As experience is
ained in performing VATS lobectomies, it is possible to per-
orm an MLND thoracoscopically, and this has now become
ur routine approach.
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Resection and mediastinal lymph node dissection 167In summary, we routinely perform anMLND in the assess-
ent of all patients undergoing curative resection for non-
mall cell carcinoma of the lung. We believe our approach
rovides accurate and complete staging information without
dded morbidity. MLND may improve survival in some pa-
ients with limited regional nodal disease, but definitive data
Figure 1 Lymph node map. At thoracotomy, the MLND
mediastinal nodes. Right lung cancers should have righ
have level 5/6 and level 7 nodes dissected routinely.
mediastinoscopy to assess right level 4 nodes because of
the right paratracheal lymph nodes.egarding this issue are not yet available. ourgical Techniques
ostoperative Considerations
otential complications of MLND compared with more lim-
ted SS include increased blood loss with more transfusion
equirement, bronchial devascularization with increased risk
d involve a complete assessment of ipsilateral thoracic
4 and level 7 nodes removed. Left lung cancers should
ft lower lobe tumors, we selectively perform cervical
cumented propensity of these cancers to metastasize toshoul
t level
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168 A.H. Moskovitz and V.W. Ruscherve, and lymphatic disruption with chylothorax. No differ-
nce has been reported in operating time, blood loss, trans-
usion requirement, or bronchial stump fistula in patients
ndergoing MLND compared with SS.8,15 Recurrent laryn-
eal nerve injury and chylothorax have been reported after
LND.22 When metastatic adenopathy in the left hilum in-
olves the recurrent laryngeal nerve, we sacrifice the nerve to
Figure 2 Lymph node map of levels 5 and 6: the aortopu
part of the standard lymph node dissection in patients wi
must be taken not to injure the left recurrent laryngealbtain complete resection of disease. In these cases, vocalord function is assessed by indirect laryngoscopy 48 to 72
ours postoperatively to evaluate the need for vocal cord
edialization. With liberal use of surgical clips and meticu-
ous sharp dissection around the location of the recurrent
erve, the risks of both nerve injury and lymphatic leak can
e minimized. As mentioned previously, MLND adds no
ore than 30 minutes to overall operative time.
ry “window” nodes. Resection of level 5 and 6 nodes is
ung tumors, especially left upper lobe carcinomas. Care
uring the dissection of level 5 lymph nodes.lmona
th left lSome thoracic surgeons have advocated a more aggressive
Resection and mediastinal lymph node dissection 169Figure 3 View of the right paratracheal lymph node dissection (level 4R). The pleura is incised vertically from the azygos
vein to the innominate artery at a point halfway between the trachea and the superior vena cava. The incision can be
extended horizontally, parallel to the azygos vein, to improve exposure. For patients who have received preoperative
chemotherapy or chemoradiotherapy, it is helpful to divide the azygos vein to facilitate exposure to the inferior portion
of the right paratracheal region and the right main pulmonary artery.
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170 A.H. Moskovitz and V.W. Ruschpproach to lymphadenectomy than what we have pre-
ented. A more extended lymphadenectomy can involve mo-
ilization of the aortic arch to obtain left paratracheal
odes.23 Alternatively, some have advocated median sternot-
my for dissection of paratracheal lymph nodes both ipsilat-
ral and contralateral to the tumor.24,25 At this time, we re-
ain unconvinced of the therapeutic advantages of extended
ymph node dissection and are concerned about its potential
ncreased morbidity. This remains an area for further inves-
Figure 4 Close-up view of the dissection of the right p
extending from the innominate artery superiorly to the
incised pleura is reflected away from the nodes, and the
Sharp or blunt dissection is used to sweep the nodes awa
posteriorly. A small vein draining from the nodal packet
carefully ligated, as should a small branch of the vagus
right recurrent laryngeal nerve at the level of the innomin
vessels and lymphatic channels entering the nodal packe
en bloc rather than piecemeal. Inferiorly, dissection is c
from this area. The deep margin of the dissection is theigation. rWe routinely perform a complete MLND in all patients
ndergoing curative resection for non-small cell carci-
oma of the lung. We believe our approach provides com-
lete staging information and may improve survival in
ome patients with limited regional nodal disease. When
erforming a thoracoscopic lobectomy, we continue to
pply our principles of complete MLND. Carefully per-
ormed, a complete MLND has virtually no added morbid-
ty and is accurate care of the patient undergoing lung
heal lymph nodes (level 4R). The entire nodal packet
obronchial angle inferiorly is removed. As shown, the
acket is grasped with a sponge stick or Babcock clamp.
the superior vena cava anteriorly and from the tracheal
e superior vena cava anteriorly should be identified and
osteriorly. Care is taken not to injure the origin of the
ry superiorly. Surgical clips are used liberally to control
bleeding is encountered if the nodal packet is removed
under the azygos vein, sweeping the lymph nodes up
rdium overlying the ascending aorta.aratrac
trache
nodal p
y from
into th
nerve p
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arriedesection for cancer cure.
Resection and mediastinal lymph node dissection 171Figure 5 Right mediastinal view, inferior compartment. The posterior mediastinal pleura is incised vertically from the
level of the main-stem bronchus to the inferior pulmonary ligament. This exposes the subcarinal, paraesophageal, and
inferior pulmonary ligament nodes.
172 A.H. Moskovitz and V.W. RuschFigure 6 View of the subcarinal lymph node dissection. The subcarinal nodal packet is grasped with a sponge stick and
is dissected off the right main-stem bronchus cranially up toward the carina. Anteriorly, the nodes are swept away from
the pericardium with either blunt or sharp dissection. Posteriorly, the nodal packet is dissected off the esophagus.
Surgical clips are used liberally to control feeding bronchiolar arterioles encountered at the main carina. Dissection is
completed by sweeping the nodal packet away from the left main-stem bronchus, so that the entire packet is removed
en bloc.
Resection and mediastinal lymph node dissection 173Figure 7 View of the aortopulmonary window dissection. The pleura is circumferentially incised around the superior
aspect of the pulmonary hilum, exposing the aortic arch, the left main pulmonary artery, the phrenic nerve, the vagus
nerve, and the origin of the left recurrent laryngeal nerve.
174 A.H. Moskovitz and V.W. RuschFigure 8 The levels 5 and 6 lymph nodes are swept away from the aortic arch, the left main pulmonary artery, and the
phrenic and vagus nerves with blunt or sharp dissection. Care is taken not to injure the origin of the left recurrent
laryngeal nerve. Surgical clips are liberally used to control all vessels and lymphatic channels.
Resection and mediastinal lymph node dissection 175Figure 9 Subcarinal and inferior mediastinal view from the left side. The pleura is incised along the posterior aspect of
the hilum down to the inferior pulmonary ligament, exposing the subcarinal, paraesophageal, and inferior pulmonary
ligament nodes.
R1
1
1
subcar
176 A.H. Moskovitz and V.W. Ruscheferences
1. Leschber G, Holinka G, Linder A: Video-assisted mediastinoscopic
lymphadenectomy (VAMLA)—a method for systematic mediastinal
lymph node dissection. Eur J Cardiothorac Surg 24:192-195, 2003
2. Cahan WG: Radical lobectomy. J Thorac Cardiovasc Surg 39:555-572,
1960
3. Cahan WG, Watson WL, Pool JL: Radical pneumonectomy. J Thorac
Cardiovasc Surg 22:449-473, 1951
4. Martini N: Mediastinal lymph node dissection for lung cancer. The
Memorial experience. Chest Surg Clin N Am 5:189-203, 1995
5. Izbicki JR, Thetter O, Habekost M, et al: Radical systematic mediastinal
lymphadenectomy in non-small cell lung cancer: A randomized con-
trolled trial. Br J Surg 81:229-235, 1994
6. Prenzel KL, Monig SP, Sinning JM, et al: Role of skip metastasis to
mediastinal lymph nodes in non-small cell lung cancer. J Surg Oncol
Figure 10 Dissection of the subcarinal nodes from the l
bronchus cranially up to the main carina. Anteriorly, th
it is mobilized away from the esophagus with blunt or sh
side than on the right side because of the aorta. Gentle re
bronchus into the operative field while maintaining exp
esophagus and aorta and provide good exposure of the s
arteries that enter the nodal packet at the main carina. T
the right main-stem bronchus and removing the entire82:256-260, 20037. Tateishi M, Fukuyama Y, Hamatake M, et al: Skip mediastinal lymph
node metastasis in non-small cell lung cancer. J Clin Oncol 57:139-
142, 1994
8. Keller SM, Adak S, Wagner H, et al: Mediastinal lymph node dissection
improves survival in patients with stages II or IIIa non-small cell lung
cancer. Ann Thorac Surg 70:358-366, 2000
9. Martini N, Flehinger BJ: The role of surgery in N2 lung cancer. Surg
Clin N Am 67:1037-1049, 1987
0. Keller SM, Vangel MG, Wagner H, et al: Prolonged survival in patients
with resected non-small cell lung cancer and single-level N2 disease.
J Thorac Cardiovasc Surg 128:130-137, 2004
1. Patterson GA, Piazza D, Pearson FG, et al: Significance of metastatic
disease in subaortic lymph nodes. Ann Thorac Surg 43:155-159, 1987
2. Izbicki JR, Passlick B, Pantel K, et al: Effectiveness of radical systematic
mediastinal lymphadenectomy in patients with resectable non-small
. The nodal packet is dissected off the left main-stem
l packet is swept off of the pericardium, and anteriorly,
section. Access to the carina is more difficult on the left
n of the lung anteriorly helps to pull the left main-stem
A narrow malleable retractor can be used to retract the
al space. Care is taken to ligate the feeding bronchiolar
section is completed by sweeping the nodes away from
inal nodal packet en bloc.eft side
e noda
arp dis
tractio
osure.
ubcarin
he discell lung cancer. Ann Surg 227:138-144, 1998
11
1
1
1
1
1
2
2
2
2
2
2
Resection and mediastinal lymph node dissection 1773. Naruke T, Goya T, Tshuchiya R, et al: The importance of surgery to
non-small cell carcinoma of lung with mediastinal lymph node metas-
tasis. Ann Thorac Surg 46:603-610, 1988
4. Watanabe Y, Shimizu J, Oda M, et al: Aggressive surgical intervention
in N2 non-small cell cancer of the lung. Ann Thorac Surg 51:253-261,
1991
5. Allen MS, Darling GE, Pechet TTV, et al: Morbidity and mortality of
major pulmonary resections in patients with early stage lung cancer:
Initial results of the randomized, prospective ACOSOG Z0030 trial.
Ann Thorac Surg. In press
6. Daniels LJ, Balderson SS, Onaitis MW, et al: Thoracoscopic lobectomy:
A safe and effective strategy for patients with stage I lung cancer. Ann
Thorac Surg 74:860-864, 2002
7. McKenna RJ, Jr.: Lobectomy by video-assisted thoracic surgery with
mediastinal node sampling for lung cancer. J Thorac Cardiovasc Surg
107:879-882, 1994
8. McKenna RJ, Jr.: Thoracoscopic lobectomy with mediastinal sampling
in 80-year-old patients. Chest 106:1902-1904, 19949. Kaseda S, Hangai N, Yamamoto S, et al: Lobectomy with extendedlymph node dissection by video-assisted thoracic surgery for lung
cancer. Surg Endosc 11:703-706, 1997
0. Watanabe S, OdaM, Tsunezuka Y, et al: Peripheral small-sized (2 cm or
less) non-small cell lung cancer with mediastinal lymph node metasta-
sis: Clinicopathologic features and patterns of nodal spread. Eur J Car-
dioThorac Surg 22:995-999, 2002
1. Oda M, Watanabe Y, Shimizu J, et al: Extent of mediastinal node me-
tastasis in clinical stage I non-small cell lung cancer: The role of sys-
tematic nodal dissection. Lung Cancer 22:23-30, 1998
2. Bollen ECM, van Duin CJ, Theunissen PHMH, et al: Mediastinal lymph
node dissection in resected lung cancer: Morbidity and accuracy of
staging. Ann Thorac Surg 55:961-966, 1993
3. Watanabe Y, Shimizu J, Oda M, et al: Improved survival in left non-
small cell N2 lung cancer after more extensive operative procedure.
Thorac Cardiovasc Surg 39:89-94, 1991
4. Hata E, Hayakawa K, Miyamoto H: Rationale for extended lymphade-
nectomy for lung cancer. Theor Surg 5:19-25, 1990
5. Hata E, Miyamoto H, Tanaka M: Superradical operation for lung can-
cer: Bilateral mediastinal dissection with or without cervical dissection.
Lung Cancer 11(Suppl 2):41-42, 1994
